@ToddNeale

Senior Medical Journalist/Associate News Editor for TCTMD

 New York City
Joined February 2012
  • Tweets3.4K
  • Following3.5K
  • Followers3.4K
283Media
I will not be using this account moving forward. Find me at the same handle over on Bluesky.
1
1
1
1,682
A new #JACC study evaluates repeat rejection after pediatric #Hearttx, finding that while it occurs less often, it remains a risk factor for graft loss. @ToddNeale reports on the findings in @TCTMD: bit.ly/3YqFmfU #cvPed

Repeat Rejection Still a Problem After Pediatric Heart Transplant

While recurrent rejection is less common than in years past, it still occurs. Black children continue to fare worse than white.

tctmd.com
1
3
628
tctmd.com/news/cardiovascula… "Warfare is the antithesis of global health. . . . Health and peace go hand in hand". @ToddNeale @TCTMD @ehj_ed @escardio @ESC_Journals @FrancescoPaneni @AlhijjiM

The Cardiovascular Consequences of War

For both civilians and military veterans, war destroys health infrastructure and has profound effects on CV risk factors.

tctmd.com
1
3
5
564
Breast artery calcification is linked with worse CV outcomes in women, according to a new study in #JACCAdvances. Learn more with @TCTMD: bit.ly/40eQor9 @ToddNeale #CardioX
3
3
736
The #1 reason for GDMT underuse in #HFrEF patients is clinical inertia, according to a research letter in #JACCHF. @ToddNeale discusses the findings in @TCTMD: bit.ly/4gzgTgt
3
3
743
Commenting to @ToddNeale, ACC VP @ChrisKramerMD, said Tri.Fr adds “to the amount of evidence that suggests that one can palliate TR with edge-to-edge repairs and improve QoL and the ability to do activities of daily living." bit.ly/4dJrlA1 #ESCCongress
2
1
742
SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden #ESCCongress tctmd.com/news/sham-pvi-cath…

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

(UPDATED) Though there are limitations, the sham-controlled trial shows “no clinically relevant placebo effect,” a researcher says.

tctmd.com
1
260
A new analysis finds renal denervation using radiofrequency energy is cost-effective, high-value intervention for patients with uncontrolled #hypertension. @TCTMD's @ToddNeale reports: bit.ly/4g400Kv

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

The technology deserves a place in hypertension treatment, although there are some open questions, one expert says.

tctmd.com
2
3
446
ACC has updated its expert consensus decision pathway for patients hospitalized with #HeartFailure. The updated guidance is published in #JACC. Get the details: bit.ly/4dIerls @TCTMD @ToddNeale
4
4
986
Whether the presence of coronary calcium should be routinely included on noncardiac CT scan reports was debated at #SCCT2024 by @MichaelJBlaha and @MBittencourtMD @Heart_SCCT @TCTMD tctmd.com/news/should-corona…

Should Coronary Calcium Always Be Noted on Noncardiac CT Reports?

Experts at SCCT debated whether that detail should be included in all cases, considering potential unintended consequences.

tctmd.com
3
11
1,215
"It adds another layer in us being able to initiate this therapy with a little more precision," @AlexRazavi says; comments from @CardiacCTGuy #SCCT2024 tctmd.com/news/coronary-calc…

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

It’s not just about the GLP-1 drug: CTA could be used to guide any number of CV prevention therapies, Maros Ferencik says.

tctmd.com
4
1
6
1,709
Excited to see the future of @Heart_SCCT as #yescct use grows. How will we achieve equitable healthcare delivery? @iamritu @DavidJHur1 @OKhaliqueMD @CardiacCTGuy @ToddVillinesMD @purviparwani @ACCinTouch @ChrisKramerMD
Todd Neale@ToddNeale19 Jul 2024
"This highlights the critical role of coronary inflammation as a potential therapeutic target in cardiovascular prevention," Kenneth Chan says #SCCT2024; commentary from @ChinnaiyanMD tctmd.com/news/coronary-infl…

Coronary Inflammation Highest in Socioeconomically Deprived Areas: ORFAN

The findings suggest a “potential therapeutic target” in the quest to reduce inequities in cardiac risk, a researcher says.

tctmd.com
5
13
2,886
"This highlights the critical role of coronary inflammation as a potential therapeutic target in cardiovascular prevention," Kenneth Chan says #SCCT2024; commentary from @ChinnaiyanMD tctmd.com/news/coronary-infl…

Coronary Inflammation Highest in Socioeconomically Deprived Areas: ORFAN

The findings suggest a “potential therapeutic target” in the quest to reduce inequities in cardiac risk, a researcher says.

tctmd.com
5
1
10
4,447
Thanks to @DrM_ODonoghue @DLBHATTMD @_WayneBatchelor @ACCmediacenter @ACCinTouch for their help on this @TCTMD tctmd.com/news/fda-add-new-d…

FDA to Add New Diversity Requirements for Certain Clinical Studies

Requiring sponsors to submit diversity action plans is a good first step to greater representation in trials, experts say.

tctmd.com
4
1
10
6,178
“I think internationally we have a collective responsibility to help this part of the world.” Prof Craig Anderson talks to @ToddNeale from @TCTMD about the under-representation of Asia-Pacific in cardiovascular clinical trials. bit.ly/4cSiMlK
1
1
554
"Despite the fact that a lion’s share of the burden of disease is going to be where the population is, we don’t tend to perform trials in this region or enroll as many patients from this region," @ProfSNicholls says; @dukwoo_park, Craig Anderson weigh in tctmd.com/news/going-global-…

Going Global: Asia-Pacific Region Not Represented in Large Clinical Trials

There’s a need to expand the reach of clinical trials, especially to the Asia-Pacific region, home to a heavy burden of CV disease.

tctmd.com
4
5
976
"Some of this, I believe, is a reasonable use, a medically justifiable use. But I do believe that there is definitely a proportion of these patients who do not need to be on a daily preventive aspirin," @MohakGuptaMD says @TCTMD tctmd.com/news/aspirin-prima…

Aspirin for Primary Prevention of CVD Remains Common in US

Negative RCTs and new recommendations sparked some decline, but many adults are still reaching for their daily pill.

tctmd.com
4
1
6
2,165
Discussing post-LAAO leaks and what to do about them at #NYValves2024 with @DrTomWaggoner @VivekReddyMD & Robert Sommer @TCTMD tctmd.com/news/leaks-after-l…

Leaks After LAAO Do Matter, Experts Agree

A “debate” had everyone on the same page: leaks worsen outcomes and need to be addressed.

tctmd.com
3
3
1,586
Although there was no significant difference in all-cause mortality between the DOAC and VKA groups at 1 year, a significant difference had emerged by 3 years and widened by 5 years, @AgamBansal5 reports #NYValves2024 @JimmyStewart00 @TCTMD tctmd.com/news/long-term-mor…

Long-term Mortality After TAVI Lower With DOACs vs VKAs

The DOAC advantage might be due to having more mechanical valve recipients in the VKA group, one expert speculates.

tctmd.com
1
4
1
15
5,938

No more items